Averin Capital
Venture capitalActively deployingNew York · Seed–Growth · 10 people tracked
Also known as AVERIN CAPITAL LLC
Find your way into Averin Capital
2,748 people in our graph share verified history with the Averin Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Averin Capital invests where technology and health converge, supporting visionary teams driving significant shifts in human health—from early disease detection and improved treatment delivery to personalized care and major medical breakthroughs. Positioned as an operator-led firm, its team includes MDs, PhDs, experienced company founders, healthcare executives, and professionals from finance and consulting, having founded or launched over 30 companies. The firm combines scientific rigor, operational expertise, and strategic insight to help entrepreneurs scale. It emphasizes being a respectful partner of choice that knows when to engage and when to step back, aiming to empower exceptional teams to reach their fullest potential.
Source: firm website, verified Sep 15, 2026.
Team · 10 people
from the firm's website & curated
Founder mafia
2 people who came through Averin Capital went on to found or lead other companies.
What they invest in
from 7 of 12 portfolio companiesDigital Health ×7Healthtech ×6Medical Devices ×5AI & Machine Learning ×1Biotech ×1Consumer ×1Hardware ×1Robotics ×1
HQs:United States×4
Investments · 12 tracked
founders shown can be your intro pathBy year:2026 · 12015 · 12 dated
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon
Riley Ennis(Co-Founder and Chief Product Officer)inCharles Roberts(Director)inGabriel Otte(Director)inAdam Stone(Chief Executive Officer and Director)Michael Altman(Chief Business Officer and Director)Shmuel (Sam) M. Cohn(Chief Financial Officer)
Co-investorsRA CapitalAgent CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAsset Management Company+8 more
Commons Clinic is an orthopedic care provider offering treatment for spine, joint, and sports medicine conditions, along with preventive health services such as full-body MRI and biomarker labs.
Digital HealthHealthtechWellness & FitnessAustin, US
Brad Hively(Director)inNick Aubin(Founder)inPaulo Marques Da Costa(Executive Officer, Director)Prithviraj Singha Roy(Director)in
BoardJohn Loser(Director)inDavid Berry(Director)
Board seatTristan Hunt· per SEC Form D · $10.1M raise · filed Jul 2026
Co-investorsCourtside VenturesFloating PointNorth South VenturesSteelSky VenturesTime BioVenturesRA Capital
Biolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device.
Digital HealthHardwareMedical Devices
Jared Tangney(Founder)inRich Yangin
Co-investorsAble PartnersAlpha Wave GlobalAphelion CapitalBOLD LongevityHikma VenturesM Ventures+2 more
CandidPro provides doctor-directed clear aligner treatment to correct misaligned bites and straighten teeth, aiming to improve oral and overall health.
Digital HealthHealthtechMedical DevicesNew York, US
Nicholas Greenfield(Executive Officer, Director)Jacob Goldfield(Director)Don Kingsborough(Director)Zachary Frankel(Executive Officer, Director)
BoardJohn Elton(Director)
Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment.
ConsumerDigital HealthHealthtechMedical Devices
Nick Greenfield(Co-founder & CEO)in
Co-investorsA-Rod CorpBessemer Venture PartnersBeyond CapitalF-Prime CapitalKube VCDigitalis Ventures+2 more
A clinical-stage artificial intelligence company using Large Medicine Models to optimize drug development, especially in late-stage clinical trials.
Co-investorsMana Ventures
Mendaera builds robotic technology, including its Focalist System for robotic-guided access and procedures such as transplant biopsy, to help healthcare providers perform reproducible clinical procedures.
Digital HealthHealthtechMedical DevicesRoboticsSan Mateo, US
Josh DeFonzo(Founder)inJason Wilson(Founder)
Co-investorsThreshold VenturesFounders FundLux CapitalFemHealth VenturesSonder CapitalMana Ventures+1 more
Pine Park Health operates a team-based primary care model that provides medical care, preventive screening, and health coordination services for patients.
Digital HealthHealthtechSan Francisco, US
Payam Parvinchiha(Chief Medical Officer)in
Co-investorsGradient VenturesY CombinatorBoxGroupUnshackled Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
GLP-1 Receptor Agonists & Biosensors CompanyHologenLiquid Biopsy CompanyWorld Economic Forum
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsFreenomeNASDAQ: FRNM
Portfolio news
latest coverage across their companies
Commons Clinic · intelligence360.news · Jul 17, 2026
Pine Park Health · healthcareitnews.com · Feb 6, 2026
Hologen AI · aimsmall.substack.com · Feb 2, 2026
Biolinq · fiercebiotech.com · Sep 29, 2025
Frequently asked questions
- How many investments has Averin Capital made?
- Averin Capital has 12 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Averin Capital invest at?
- Averin Capital invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Averin Capital focus on?
- Averin Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Robotics.
- Where is Averin Capital located?
- Averin Capital is headquartered in New York, US.
- Who does Averin Capital co-invest with?
- Averin Capital most often shares deals with Andreessen Horowitz, Bessemer Venture Partners, CRV (Charles River Ventures), among 33 tracked co-investors.
From the blog
visit blog ↗Averin Capital has written on structural barriers to AI adoption in biotech: talent loss driven by job design rather than compensation, liability gaps blocking clinical AI deployment, and state-level regulatory changes creating alternative pathways for experimental medicine commercialization." AI summary
Media · Podcasts & interviews
featuring the teamAverin Capital Managing Partner David Berry on what it was like to work with Bob Langer.
BiotechTV · David Berry
Transforming Healthcare Through Technology: Insights from Averin Capital’s David Berry
Mission Matters Money with Adam Torres · David Berry
Images
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
NJF Capital is the venture investment arm of NJF Holdings, the private investment group founded by Nicole Junkermann. It backs transformative entrepreneurs building industry-defining technologies with global scale potential.